Contribution of antioxidants to preventive effect of mesna in cyclophosphamide-induced hemorrhagic cystitis in rats

被引:37
作者
Yildirim, I
Korkmaz, A
Oter, S [1 ]
Ozcan, A
Oztas, E
机构
[1] Gulhane Mil Med Acad, Dept Physiol, Ankara, Turkey
[2] Gulhane Mil Med Acad, Dept Urol, Ankara, Turkey
[3] Gulhane Mil Med Acad, Dept Pathol, Ankara, Turkey
[4] Gulhane Mil Med Acad, Dept Med Hist & Embryol, Ankara, Turkey
关键词
cyclophosphamide; mesna; antioxidants; cystitis;
D O I
10.1007/s00280-004-0822-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The aim of this study was to evaluate whether combination of antioxidants and mesna may prevent cystitis induced by cyclophosphamide better than mesna alone. Materials and methods: A total of 46 male Spraque-Dawley rats were divided into six groups. Five groups received single dose of cyclophosphamide (CP, 100 mg/kg) intraperitoneally with the same time intervals: group 2 received CP only, group 3 received mesna (21.5 mg/kg for three times), group 4 beta-carotene ( 20 mg/kg for two times) and mesna, group 5 received alpha-tocopherol ( 20 mg/kg for two times) and mesna, and group 6 received melatonin ( 5 mg/kg for two times) and mesna on the day of CP injection. Group 1 served as control. Results: CP injection resulted in severe cystitis. Mesna has showed meaningful but not full protection against CP toxicity. Although beta-carotene did not show any additional beneficial effect when combined with mesna, alpha-tocopherol and especially melatonin with mesna resulted full protection that the pathologist, blinded to the slides, could not differ from sham control. Conclusion: Oxidants may be important in the pathogenesis of CP-induced cystitis. Melatonin and alpha-tocopherol may help to ameliorate bladder damage along with other drugs such as mesna and diuretics.
引用
收藏
页码:469 / 473
页数:5
相关论文
共 19 条
[1]  
[Anonymous], LIFE SCI
[2]  
Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
[3]   STUDIES ON THE UROTOXICITY OF OXAZAPHOSPHORINE CYTOSTATICS AND ITS PREVENTION .1. EXPERIMENTAL STUDIES ON THE UROTOXICITY OF ALKYLATING COMPOUNDS [J].
BROCK, N ;
POHL, J ;
STEKAR, J .
EUROPEAN JOURNAL OF CANCER, 1981, 17 (06) :595-607
[4]  
Crow JP, 1996, ADV EXP MED BIOL, V387, P147
[5]   Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury [J].
Cuzzocrea, S ;
Reiter, RJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 426 (1-2) :1-10
[6]   Pharmacokinetic interaction between ondansetron and cyclophosphamide during high-dose chemotherapy for breast cancer [J].
Gilbert, CJ ;
Petros, WP ;
Vredenburgh, J ;
Hussein, A ;
Ross, M ;
Rubin, P ;
Fehdrau, R ;
Cavanaugh, C ;
Berry, D ;
McKinstry, C ;
Peters, WP .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (06) :497-503
[7]   Combined intravenous and oral mesna in outpatients treated with ifosfamide [J].
Goren, MP ;
McKenna, LM ;
Goodman, TL .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (05) :371-375
[8]   EVALUATION OF MISOPROSTOL CYTOPROTECTION OF THE BLADDER WITH CYCLOPHOSPHAMIDE (CYTOXAN) THERAPY [J].
GRAY, KJ ;
ENGELMANN, UH ;
JOHNSON, EH ;
FISHMAN, IJ .
JOURNAL OF UROLOGY, 1986, 136 (02) :497-500
[9]   Involvement of nitric oxide and hyperbaric oxygen in the pathogenesis of cyclophosphamide induced hemorrhagic cystitis in rats [J].
Korkmaz, A ;
Oter, S ;
Deveci, S ;
Ozgurtas, T ;
Topal, T ;
Sadir, S ;
Bilgic, H .
JOURNAL OF UROLOGY, 2003, 170 (06) :2498-2502
[10]   Urinary excretion of ifosfamide, 4-hydroxyifosfamide, 3- and 2-dechloroethylifosfamide, mesna, and dimesna in patients on fractionated intravenous ifosfamide and concomitant mesna therapy [J].
Kurowski, V ;
Wagner, T .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 39 (05) :431-439